Ocugen logo

Ocugen Share Price (NASDAQ: OCGN)

$1.04

-0.01

(-0.95%)

Live

Last updated on

Check the interactive Ocugen Stock chart to analyse performance

Ocugen stock performance

as on August 18, 2025 at 11:41 PM IST

  • Today's Low:$1.02
    Today's High:$1.06

    Day's Volatility :3.32%

  • 52 Weeks Low:$0.52
    52 Weeks High:$1.40

    52 Weeks Volatility :63.21%

Ocugen Stock Returns

PeriodOcugen IncSector (Health Care)Index (Russel 2000)
3 Months
36.4%
2.3%
0.0%
6 Months
44.03%
-5.8%
0.0%
1 Year
-18.6%
-10.9%
0.0%
3 Years
-57.14%
2.8%
-11.6%

Ocugen Inc Key Stats

Check Ocugen key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.05
Open
$1.03
Today's High
$1.055
Today's Low
$1.02
Market Capitalization
$327.9M
Today's Volume
$1.5M
52 Week High
$1.4
52 Week Low
$0.515
Revenue TTM
$4.8M
EBITDA
$-52.3M
Earnings Per Share (EPS)
$-0.19
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-569.99%

Stock Returns calculator for Ocugen Stock including INR - Dollar returns

The Ocugen stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ocugen investment value today

Current value as on today

₹84,694

Returns

₹15,306

(-15.31%)

Returns from Ocugen Stock

₹19,380 (-19.38%)

Dollar Returns*

₹4,073 (+4.07%)

Indian investors sentiment towards Ocugen Stock

-19%

Period: Jul 18, 2025 to Aug 17, 2025. Change in 30 Days versus previous period

Search interest for Ocugen Stock from India on INDmoney has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Ocugen Inc

  • Name

    Holdings %

  • BlackRock Inc

    6.70%

  • Vanguard Group Inc

    5.05%

  • Geode Capital Management, LLC

    2.36%

  • State Street Corp

    2.03%

  • UBS Group AG

    1.49%

  • GMT Capital Corp

    1.42%

Analyst Recommendation on Ocugen Stock

Rating
Trend

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Ocugen(by analysts ranked 0 to 5 stars)

Ocugen Share Price Target

What analysts predicted

Upside of 525.0%

Target:

$6.50

Current:

$1.04

Ocugen share price target is $6.50, a slight Upside of 525.0% compared to current price of $1.04 as per analysts' prediction.

Ocugen Stock Insights

  • Price Movement

    In the last 6 months, OCGN stock has moved up by 44.0%
  • OCGN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 67.4% return, outperforming this stock by 82.7%
  • OCGN vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 100.9% return, outperforming this stock by 159.9%
  • Price to Sales

    ForOCGN every $1 of sales, investors are willing to pay $65.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.6 for every $1 of sales.

Ocugen Inc Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$4.1M
↓ 32.82%
Net Income
$-54.1M
↓ 14.31%
Net Profit Margin
-1.3K%
↓ 287.99%

Ocugen Technicals Summary

Sell

Neutral

Buy

Ocugen is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Ocugen Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Ocugen Inc logo
3.96%
44.03%
-18.6%
-57.14%
118.7%
Regeneron Pharmaceuticals, Inc. logo
6.39%
-14.65%
-51.51%
-6.14%
-7.82%
Beone Medicines Ltd logo
10.08%
34.96%
66.94%
83.8%
36.85%
Vertex Pharmaceuticals Incorporated logo
-14.33%
-15.0%
-19.52%
31.35%
45.44%
Alnylam Pharmaceuticals, Inc. logo
40.06%
79.56%
63.55%
107.86%
227.15%

About Ocugen Inc

Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is involved in the development of OCU200, a novel fusion protein for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.
Organization
Ocugen
Employees
95
CEO
Dr. Shankar Musunuri M.B.A., Ph.D.
Industry
Health Technology

Key Management of Ocugen Inc

NameTitle
Dr. Shankar Musunuri M.B.A., Ph.D.
Co-Founder, CEO & Chairman
Dr. Uday B. Kompella Ph.D.
Co-founder & Independent Director
Dr. Arun Upadhyay Ph.D.
Chief Scientific Officer and Head of Research & Development
Dr. Huma Qamar CMI, M.D., M.P.H.
Chief Medical Officer
Mr. Ramesh Ramachandran C.M.A., CPA, M.B.A.
Chief Accounting Officer, Principal Financial Officer & Principal Accounting Officer
John Kouch J.D.
General Counsel
Ms. Tiffany J. Hamilton M.B.A.
AVP & Head of Corporate Communications
Ms. Kristen Craft
Head of People & Culture
Dr. Vijay Tammara Ph.D.
Chief Development Officer
Ms. Jyothy Pillai M.S.
VP & Head of Regulatory & Quality

Important FAQs about investing in OCGN Stock from India :

What is Ocugen share price today?

Ocugen share price today is $1.04 as on . Ocugen share today touched a day high of $1.06 and a low of $1.02.

What is the 52 week high and 52 week low for Ocugen share?

Ocugen share touched a 52 week high of $1.40 and a 52 week low of $0.52. Ocugen stock price today, is trending at $1.04, lower by 25.71% versus the 52 week high.

How to invest in Ocugen Stock (OCGN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Ocugen on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ocugen Shares that will get you 1.4423 shares as per Ocugen share price of $1.04 per share as on August 18, 2025 at 11:41 PM IST.

What is the minimum amount required to buy Ocugen Stock (OCGN) from India?

Indian investors can start investing in Ocugen (OCGN) shares with as little as ₹87.3775 or $1 (as of August 18, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹873.77 in Ocugen stock (as per the Rupee-Dollar exchange rate as on August 18, 2025). Based on Ocugen share’s latest price of $1.04 as on August 18, 2025 at 11:41 PM IST, you will get 9.6154 shares of Ocugen. Learn more about fractional shares .

What are the returns that Ocugen has given to Indian investors in the last 5 years?

Ocugen stock has given 118.7% share price returns and 16.91% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?